首页> 外文会议>ASME Bioengineering Conference >HEMODYNAMICS OF ABDOMINAL AORTIC ANEURYSM AND ITS CLINICAL RELEVANCE IN PATIENTS WITH INFRARENAL STENT-GRAFT IMPLANTATION
【24h】

HEMODYNAMICS OF ABDOMINAL AORTIC ANEURYSM AND ITS CLINICAL RELEVANCE IN PATIENTS WITH INFRARENAL STENT-GRAFT IMPLANTATION

机译:腹主动脉瘤的血流动力学及其在植物支架植入术患者中的临床相关性

获取原文

摘要

In 2008 the overall rate of death attributable to cardiovascular disease, or CVD, is 244.8 per 100,000. On the basis of these mortality rate data, one American dies due to CVD on an average of every 39 seconds. Of these deaths, abdominal aortic aneurysm (AAA) accounts for 11,079 [1]. Although an estimate of the total economic burden of AAA is not available, the average cost per discharge for a ruptured AAA exceeded $93,000 in 2003 [2]. Generally, an abdominal aortic aneurysm (AAA) is an irreversible focal dilation of an artery to 1.5 times its normal diameter [3]. AAAs are characterized by the destruction of elastin and collagen in the media and adventitia, smooth muscle cell loss with thinning of the medial wall, infiltration of lymphocytes and macrophages, and neovascularization [4, 5]. The most common treatment for AAA is endovascular aneurysm repair (EVAR) by implanting a stent-graft (SG) to the affected segment for shielding the aneurysm wall from the blood pressure, eliminating blood circulation in the aneurysm intra-sac, and thus prevent wall rupture [6]. Traditionally bare metal stents were used in these surgeries but with high failure rate due to restenosis and thrombosis. Alternatively, drug-eluting stents (DES) were introduced as a remedy but still, the safety of DES needs to be re-examined as DES have been implicated in higher rates of late stent thrombosis (LST) [7]. The causes of majority of SG failures include seepage of blood into the cavity (endoleak), SG migration, and SG fatigue and fracture. Among these causes, endoleak is recognized as the main problem associated with SG, and is used as an endpoint in clinical trials [8]. Endoleak is defined as a blood flow external to the stent-graft and inside the aneurysm sac [9], and can be identified in as high as 52% of patients after EVAR. The existence of endoleak raises concerns of possible aneurysm enlargement and rupture. [10]. A classification system has evolved in which endoleak is organized into five categories [11], and they are highly correlated with peak flow pressure and stress concentrated locally along the interface between SG and aneurysm sac. It has been evidenced that early detection of the locations of endoleak will reduce the risk of SG failure. Therefore, the aim of this study is to quantify hemodynamics in AAA patients after SG implantation to elucidate the effect of flow-induced mechanical forces on the appearance of endoleak, for better endoleak management in clinics and to assist new SG designs.
机译:2008年,归因于心血管疾病或CVD的总体死亡率为每10万人244.8。在这些死亡率数据的基础上,一个美国的死于CVD平均每39秒。这些死亡中,腹主动脉瘤(AAA)占11,079 [1]。虽然估计无法获得AAA的经济总和,但2003年,AAA破裂的平均成本超过了93,000美元[2]。通常,腹主动脉动脉瘤(AAA)是动脉的不可逆焦点至其正常直径的1.5倍[3]。 AAA的特点是在培养基和外膜中破坏弹性蛋白和胶原蛋白,平滑肌肉细胞损失,细腻的内侧壁,淋巴细胞浸润和巨噬细胞,新生血管形成[4,5]。通过将支架移植物(SG)植入受影响的段来屏蔽动脉瘤壁的血压,消除动脉瘤内囊中的血液循环,是血管内动脉瘤修复(EVAR)是血管内动脉瘤修复(EVAR),从而防止囊动脉瘤中的血液循环,从而防止壁破裂[6]。传统上裸露的金属支架用于这些手术中,但由于再狭窄和血栓形成,具有高的失败率。或者,将药物洗脱支架(DES)作为补救措施引入,但仍然需要重新检查DES的安全性,因为DES与晚期支架血栓形成(LST)的更高速率涉及较高的速率[7]。大多数SG故障的原因包括血液渗入腔(Endoleak),SG迁移和SG疲劳和骨折。在这些原因中,EndoLeak被认为是与SG相关的主要问题,并用作临床试验中的终点[8]。 Endoleak被定义为支架移植物外部的血液流动和动脉瘤SAC [9]内部,并且可以在EVAR之后高达52%的患者鉴定。 EndoLeak的存在提出了可能的动脉瘤增大和破裂的担忧。 [10]。分类系统进化在其中螺注入五类[11],它们与沿着SG和动脉瘤囊之间的界面局部集中的峰流量压力和应力高度相关。已经证明,早期检测endoleak的位置将降低SG失效的风险。因此,本研究的目的是在SG植入后量化AAA患者的血流动力学,以阐明流动诱导的机械力对肠胃外壳的影响,以便在诊所的更好的终端恐慌管理和协助新的SG设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号